The PE Ratio as of September 2024 (TTM) for Compass Therapeutics, Inc. (CMPX) is -4.80

According to Compass Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.80. This represents a change of -22.48% compared to the average of -6.19 of the last 4 quarters.

Compass Therapeutics, Inc. (CMPX) Historical PE Ratio (quarterly & annually)

How has CMPX PE Ratio performed in the past?

The mean historical PE Ratio of Compass Therapeutics, Inc. over the last ten years is -9.11. The current -4.80 PE Ratio has changed 5.17% with respect to the historical average. Over the past ten years (40 quarters), CMPX's PE Ratio was at its highest in in the June 2018 quarter at 0. The PE Ratio was at its lowest in in the June 2020 quarter at -19.93.

Compass Therapeutics, Inc. (CMPX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Compass Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Compass Therapeutics, Inc. (CMPX) Average PE Ratio

How has CMPX PE Ratio performed in the past?

The current PE Ratio of Compass Therapeutics, Inc. (CMPX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Compass Therapeutics, Inc. (CMPX) PE Ratio vs. Peers

How is CMPX’s PE Ratio compared to its peers?

Compass Therapeutics, Inc.’s PE Ratio is greater than IDEAYA Biosciences, Inc. (-18.82), greater than AnaptysBio, Inc. (-6.20), less than MeiraGTx Holdings plc (-2.90), greater than Keros Therapeutics, Inc. (-11.93), less than Homology Medicines, Inc. (-0.01), less than Monte Rosa Therapeutics, Inc. (-3.09), greater than NewAmsterdam Pharma Company N.V. (-7.13), less than Inventiva S.A. (-0.88), greater than Cullinan Oncology, Inc. (-6.53), less than PepGen Inc. (-3.32), greater than Tyra Biosciences, Inc. (-14.58), less than Vigil Neuroscience, Inc. (-1.73), less than PureTech Health plc (-4.15), less than Aerovate Therapeutics, Inc. (-0.63), greater than Enliven Therapeutics, Inc. (-12.98), greater than MoonLake Immunotherapeutics (-58.59), greater than Structure Therapeutics Inc. (-19.79), less than Replimune Group, Inc. (-3.27), greater than Nuvectis Pharma, Inc. (-4.97), less than Lyra Therapeutics, Inc. (-0.18), less than Kronos Bio, Inc. (-0.54), less than Gossamer Bio, Inc. (-2.55),

Build a custom stock screener for Compass Therapeutics, Inc. (CMPX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Compass Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Compass Therapeutics, Inc. (CMPX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Compass Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.